Continuous innovation in antiviral and antibacterial therapies is essential to combat evolving pathogens and antimicrobial resistance. New treatment strategies are improving patient outcomes and addressing unmet medical needs.
This track examines novel drug discovery, targeted therapies, antimicrobial peptides, combination treatments, and next-generation therapeutic technologies. Experts will discuss current clinical developments and future treatment options.
Participants will gain valuable knowledge about innovative pharmaceutical research, clinical applications, and therapeutic advances in infectious disease management.